Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults.
abobotulinumtoxinA
patients
post-stroke
shoulder pain
spasticity
therapeutic goal
Journal
Toxins
ISSN: 2072-6651
Titre abrégé: Toxins (Basel)
Pays: Switzerland
ID NLM: 101530765
Informations de publication
Date de publication:
20 11 2022
20 11 2022
Historique:
received:
12
08
2022
revised:
30
09
2022
accepted:
25
10
2022
entrez:
24
11
2022
pubmed:
25
11
2022
medline:
29
11
2022
Statut:
epublish
Résumé
Botulinum toxin type A is approved for the focal treatment of spasticity; however, the effectiveness of abobotulinumtoxinA (aboBoNT-A) in patients with shoulder pain who have set reduced pain as a treatment goal is understudied. In addition, some patients encounter delays in accessing treatment programs; therefore, the suitability of aboBoNT-A for pain reduction in this population requires investigation. These factors were assessed in aboBoNT-A-naive Brazilian patients in a post hoc analysis of data from BCause, an observational, multicenter, prospective study (NCT02390206). Patients (N = 49,
Identifiants
pubmed: 36422983
pii: toxins14110809
doi: 10.3390/toxins14110809
pmc: PMC9692702
pii:
doi:
Substances chimiques
abobotulinumtoxinA
EC 3.4.24.69
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Multicenter Study
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Références
Brain Inj. 2005 Aug 20;19(9):667-73
pubmed: 16195179
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):845-8
pubmed: 17088333
Toxins (Basel). 2015 Aug 14;7(8):3127-54
pubmed: 26287242
PM R. 2009 Sep;1(9):842-51
pubmed: 19769919
Eur J Pain. 2002;6(6):467-74
pubmed: 12413435
J Rehabil Med. 2007 Jul;39(6):440-7
pubmed: 17624477
Arch Phys Med Rehabil. 2015 Dec;96(12):2214-20
pubmed: 26189200
Postgrad Med J. 2001 Oct;77(912):645-9
pubmed: 11571371
Arq Neuropsiquiatr. 2017 Feb;75(2):103-106
pubmed: 28226079
Muscle Nerve. 2018 Feb;57(2):245-254
pubmed: 28590525
J Pain Symptom Manage. 2000 Jul;20(1):44-9
pubmed: 10946168
Top Stroke Rehabil. 2012 Nov-Dec;19(6):514-22
pubmed: 23192716
Toxins (Basel). 2020 Jul 02;12(7):
pubmed: 32630737
Stroke. 2018 Sep;49(9):2129-2137
pubmed: 30354975
Semin Neurol. 2021 Feb;41(1):67-74
pubmed: 33469900
Pain Manag. 2020 Nov;10(6):411-420
pubmed: 33073703
Qual Life Res. 2015 Apr;24(4):845-50
pubmed: 25347978
Int J Mol Sci. 2020 Nov 18;21(22):
pubmed: 33218099
Pan Afr Med J. 2020 Feb 25;35:55
pubmed: 32523646
J Rehabil Med. 2020 Jun 11;52(6):jrm00068
pubmed: 32451555
Toxins (Basel). 2017 Dec 28;10(1):
pubmed: 29283397
Lancet Neurol. 2015 Oct;14(10):992-1001
pubmed: 26318836
Front Neurol. 2021 May 28;12:668370
pubmed: 34122312
Front Neurol. 2020 Feb 28;11:104
pubmed: 32184753
Brain Behav. 2018 Dec;8(12):e01162
pubmed: 30585449
J Rehabil Med. 2021 Jan 1;53(1):jrm00133
pubmed: 33206198
Eur J Pain. 2000;4(3):313-5
pubmed: 10985876
Stroke. 2007 Feb;38(2):343-8
pubmed: 17185637
Clin Rehabil. 2002 May;16(3):276-98
pubmed: 12017515
Stroke. 2011 Apr;42(4):1146-51
pubmed: 21372310
Clinics (Sao Paulo). 2019;74:e905
pubmed: 31038564
Neurology. 2017 Nov 28;89(22):2245-2253
pubmed: 29093068
Nat Clin Pract Neurol. 2008 Dec;4(12):676-85
pubmed: 19043424
BMJ Open. 2013 Mar 18;3(3):
pubmed: 23512837
Clin Rehabil. 2009 Apr;23(4):362-70
pubmed: 19179355
eNeurologicalSci. 2016 Mar 02;2:21-30
pubmed: 29473058
Am J Phys Med Rehabil. 2011 Sep;90(9):768-80
pubmed: 21430513
Toxins (Basel). 2020 Dec 04;12(12):
pubmed: 33291807
Arq Neuropsiquiatr. 2019 Sep 05;77(8):568-573
pubmed: 31508683
Arq Neuropsiquiatr. 2008 Jun;66(2A):213-5
pubmed: 18545785
BMJ Open. 2013 Jun 20;3(6):
pubmed: 23794582